Landscapes / Companies
Evopoint Biosciences Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
2 in Phase 2
Drugs
4
in active trials · 7 in all
Trials
11 active
21 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 31 Dec 2026Phase 1/2 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Pancreatic Carcinoma and 4 more | ||||
| Open drug page | |||||
— |
Phase 3 | Jan 2027Phase 2 trial completes | |||
| Next date | Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Relapsed/Refractory Peripheral T Cell Lymphoma, Metastatic Castrate-Resistant Prostate Cancer and 8 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 14 Feb 2027Phase 1/2 trial completes | |||
| Next date | 14 Feb 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Tumor, Solid | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021